Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors

Abroad (travel likely)RecruitingPHASE1

Conditions

Anatomic Stage III Breast Cancer AJCC v8 · Anatomic Stage IV Breast Cancer AJCC v8 · Metastatic Breast Carcinoma · Metastatic Malignant Solid Neoplasm · Metastatic NUT Carcinoma · Unresectable Breast Carcinoma · Unresectable Malignant Solid Neoplasm · Unresectable NUT Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Keck Medicine of USC Koreatown, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · 213-388-0908
    Contact: Principal Investigator (Robert Hsu)
  • Los Angeles General Medical Center, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · uscnorrisinfo@med.usc.edu · 323-865-0451
    Contact: Principal Investigator (Robert Hsu)
  • USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · 323-865-0451
    Contact: Principal Investigator (Robert Hsu)
  • USC Norris Oncology/Hematology-Newport Beach, Newport Beach, California, United States

    Contact: Study coordinator (Site Public Contact) · 323-865-0451
    Contact: Principal Investigator (Robert Hsu)
  • Dana-Farber Cancer Institute, Boston, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · 877-442-3324
    Contact: Principal Investigator (Jia Luo)
  • University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-647-8073
    Contact: Principal Investigator (Liza C. Villaruz)
  • UT MD Anderson Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (Site Public Contact) · askmdanderson@mdanderson.org · 866-632-6789
    Contact: Principal Investigator (Sarina A. Piha-Paul)
Study leads
  • Jia Luo

    Principal Investigator

    Dana-Farber - Harvard Cancer Center LAO